3D Printed Pharmaceuticals 🗓

How will 3D printing impact the pharmaceutical and nutraceutical paradigms? Join this exciting and explorative conversation with a panel of international experts and entrepreneurs to find out. Empowered by versatile tools, creative usage in the pharmaceutical space has expanded our abilities to develop new personalized medicines and nutriceuticals at the point of care. Old APIs can now be incorporated into various designs to create new “polypills” or delicious and attractive medications that are more palatable to children. Alternative drug delivery methods are also being developed to enable the incorporation of existing and new APIs into innovative medical approaches. With the recent growth of the new GLP-1 compound medicine industry, the economics of compound pharmacies could be at a pivotal point. 3D printed customizable pills in healthcare could play an even more significant role with the rise of the compound pharmacy industry. 

With the concurrent AI revolution (especially in terms of better healthcare data management), this industry is likely better positioned to meet the demand in healthcare, solving problems large or small. It will improve existing markets and expand into new territories (Think: 15000 pills to 50 pills one day for drug-resistant Tuberculosis by improved personalization and patient compliance, for example). 

This digital native manufacturing approach enables rapid iterations for new products and tailored medicine based on personal health data, leading to improved outcomes and creating new opportunities for drug manufacturers. As clinical trials and new products roll out globally, the next decade is positioned to make personalized, on-demand health solutions a daily reality. 

Note: If you can’t make it on time, you can register and watch the conversation on demand for a week after the live event ends.

Live event participation is FREE to the public.

You can subscribe here to receive future emails.
Want to sponsor our next virtual event? Email: info@3dheals.com

Apply to speak or sponsor the event: info@3dheals.com

Subscribe here to receive event emails.

Speakers:

Alvaro Goyanes

Alvaro Goyanes is the co-founder and CEO of FABRX, the first company dedicated to developing 3D printing technology for the fabrication of personalized medicines and medical devices. He is also an Honorary Lecturer at University College London- School of Pharmacy (UK) and an Associate Professor at the Faculty of Pharmacy, University of Santiago de Compostela (Spain).
A pioneer in the field, Alvaro was among the first researchers to explore the potential of 3D printing for manufacturing oral dosage forms and medical devices. Recognized as a world expert in 3D-printed medicines, he has been listed among the World’s Most Highly Influential Researchers by Web of Science for six consecutive years since 2019.

Seng Han LIM

Dr Seng Han LIM is currently the Technical Co-Founder & Chief Operating Officer of Craft Health Pte Ltd, where he oversees both operations and R&D. He is instrumental in the development of the Craft Health 3D Printing Platform, used to 3D print pharmaceuticals and nutraceuticals without heat or UV curing.

Previously a National University of Singapore (NUS) President Graduate Fellow at the Department of NUS Pharmacy where he earned his PhD, his research focused on 3D printing in the field of personalized drug delivery and testing systems. He is highly experienced in the 3D printing of medications as per his PhD thesis and has published more than 15 peer reviewed research articles and hold several patents. Prior to that, he graduated with a First Class Honours from NUS Pharmacy in 2011 and received a Singapore General Hospital (SGH) Mid-Term Sponsorship where he practised as a registered pharmacist.

Thomas Forbes

Tom Forbes is a research scientist at the National Institute of Standards and Technology (NIST), an agency of the U.S. Department of Commerce, which advances critical measurement solutions and promotes equitable standards to stimulate innovation and industrial competitiveness. Tom is a member of the Materials Measurement Science Division, where he develops scientific and engineering solutions for areas such as human health and safety, additive manufacturing, and public safety, security, and forensics. Recent advancements in 3D printing, additive manufacturing, and continuous manufacturing have introduced a range of unique and agile instrumentation for pharmaceutical production – aimed at improving quality, addressing shortages, and improving time-to-market. Tom leads a program at NIST investigating the measurement science and potential standards needs for a pharmaceutical production paradigm that shifts toward agile distributed and point-of-care manufacturing. Many of the advanced technologies entering this space revolve around additive manufacturing and 3D printing.

Niklas Sandler

Niklas Sandler, PhD (Pharm.), Founder and Chief Technology Officer (CTO) at CurifyLabs. He has extensive experience in academia and pharmaceutical industry. Since 2010 he has worked with and published about additive manufacturing (3D printing) applications in pharma. CurifyLabs was founded in 2021 and is offering a unique 3D printing based approach to compounding medicines in pharmacies and hospital pharmacies personalized medicines which is in clinical use in more than 10 countries in Europe and US.

Moderator:

Dr. Jenny Chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.